New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- National Games showcase Guangdong, Hong Kong, Macao cuisine
- Xiangyang legislators expand public feedback channels
- Beijing court cracks down on medical fraud cases
- Gambling ringleader sent back to China
- Intl experts raise alarm over the accelerating loss of biodiversity
- China's power battery industry records nearly 50% jump in sales
